Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 12/18/202
-
Total 13F shares
-
5,196,582
-
Share change
-
+5,196,582
-
Total reported value
-
$954,744
-
Price per share
-
$0.20
-
Number of holders
-
21
-
Value change
-
+$954,744
-
Number of buys
-
21
Institutional Holders of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) as of Q1 2025
As of 31 Mar 2025,
Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,196,582 shares.
The largest 10 holders included
AQR Arbitrage LLC, Shaolin Capital Management LLC, CSS LLC/IL, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP, TENOR CAPITAL MANAGEMENT Co., L.P., K2 PRINCIPAL FUND, L.P., and Verition Fund Management LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.